KEY INVESTMENT HIGHLIGHTS

• Exclusive distributor of scientific equipment for Morocco and Africa, targeting education, industry (including pharmaceuticals, aeronautics and automotive), healthcare, as well as research laboratories.
• Resilient businesś; stable demand in times of crisis with a CAGR of 15.3% with average sales of 31MDH over the period 2021-20223 and an estimated sales volume of 40Mdh in 2024.
• A debt-free company with a structurally positive net cash position.
• A steadily improving EBIDTA margin at 24% in 2023 and double-digit net profitabilitý at nearly 13%.